课题基金 / 基金详情

项目摘要

项目成果

SOBIN KIM的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在此,我们提出开发一种用于基因表达水平变化的基因组分析的新方法。一组基因表达模式的变化被认为是这些基因的生理功能的概况,并且可以说明复杂疾病如乳腺癌在不同阶段的分子特征。因此,如本文所提出的,使用准确、快速和具有成本效益的方法有效测量基因表达水平将允许理解乳腺癌的发展和诊断疾病。所提出的方法利用两种方法,固相捕获单碱基延伸(SPC-SBE)方法和真实的竞争性PCR(rcPCR)方法。SPC-SBE是PI开发的一种多重基因分型方法,采用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)和分子亲和系统。SPC-SBE方法包括在MS测量之前特异性分离DNA延伸片段的程序,从而在遗传变异的多重基因分型中实现更高的通量和准确性。由于SPC-SBE提供了一个强大的杂合SNP的基因分型,具有更高水平的准确性和通量,我们假设该方法可以是一个强大的基因表达分析的方法,当适应rcPCR方法。具体研究内容包括:(1)利用SPC-SBE和rcPCR技术分析50个基因的表达水平。我们将首先使用SPC-SBE和rcPCR开发表达分析工具。我们将使用一个经过充分研究的系统,视网膜发育过程中的基因表达变化,作为模型来建立所提出的方法。(2)MALDI-TOF MS样品制备过程的优化。我们将通过优化样品晶体制备和数据分析来提高定量基因分型(从而提高基因表达水平测量)的准确性。(3)用于乳腺癌样本的拟议系统的验证。我们将展示我们的系统监测乳腺癌基因表达的变化。将结果与以往的研究进行比较。所提出的方法将允许高通量,准确和具有成本效益的乳腺癌基因表达水平的变化监测。因此,该方法将提供乳腺癌亚型的简单分类和进展阶段的准确确定,这对于个体患者评估和个性化治疗至关重要。
英文摘要
DESCRIPTION (provided by applicant): Here we propose to develop a new approach for genomic analysis of gene expression level changes. Changes in the expression pattern of a group of genes are believed to profile the physiological functions of those genes, and can illustrate the molecular characteristic of a complex disease such as breast cancer at various stages. Therefore, efficient measurements of gene expression level using an accurate, rapid and cost-effective way as proposed here will allow for the understanding of the breast cancer development and for the diagnosis of the disease. The proposed approach utilizes two methods, the solid phase capturable single base extension (SPC-SBE) method and the real competitive PCR (rcPCR) approach. SPC-SBE is a multiplex genotyping method developed by the PI that employs matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and a molecular affinity system. The SPC-SBE method includes a procedure for the specific isolation of DNA extension fragments prior to the MS measurement, allowing higher throughput and accuracy in multiplex genotyping of genetic variations. Since SPC-SBE offers a robust genotyping of heterozygous SNPs with higher level of accuracy and throughput, we hypothesize the method can be a robust approach for gene expression analysis, when adapting the rcPCR approach. The specific aims of the proposed research include: (1) Analysis of the expression level of 50 genes using SPC- SBE and rcPCR. We will first develop an expression analysis tool using SPC-SBE and rcPCR. We will use a well studied system, gene expression changes during retinal development, as a model to establish the proposed method. (2) Optimization of the sample preparation process for MALDI-TOF MS. We will enhance the accuracy of the quantitative genotyping (and thus the gene expression level measurement) by optimizing the sample crystal preparation and data analysis. (3) Verification of the proposed system for breast cancer samples. We will demonstrate our system for monitoring gene expression changes in breast cancer. The result will be compared with previous studies. The proposed method will permit high throughput, accurate and cost-effective monitoring of gene expression level changes in breast cancer. Therefore, the method will provide easy classification of breast cancer subtypes and accurate determination of progression stages, which is critical for individual patient assessment and for personalized treatment.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Simultaneous determination of multiple mRNA levels utilizing MALDI-TOF mass spectrometry and biotinylated dideoxynucleotides.
利用 MALDI-TOF 质谱法和生物素化双脱氧核苷酸同时测定多个 mRNA 水平。
DOI: 10.1261/rna.1859810
发表时间: 2010
期刊: RNA (New York, N.Y.)
影响因子: --
作者: [Duffield,DanielScott, Cai,Li, Kim,Sobin]
通讯作者: Kim,Sobin
Analysis of gene expression changes in breast cancer using MALDI-TOF MS
  • 批准号:
    7214469
  • 项目类别:
  • 资助金额:
    $7.18万
  • 财政年份:
    2006
  • 负责人:
    SOBIN KIM
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
  • 批准号:
    82470907
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2024
  • 负责人:
    余学锋
  • 依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: